<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100971942</journal-id>
<journal-id journal-id-type="pubmed-jr-id">26012</journal-id>
<journal-id journal-id-type="nlm-ta">North Carol Law Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">North Carol Law Rev</journal-id>
<journal-title-group>
<journal-title>North Carolina law review</journal-title>
</journal-title-group>
<issn pub-type="ppub">0029-2524</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31871365</article-id>
<article-id pub-id-type="pmc">6927684</article-id>
<article-id pub-id-type="manuscript">NIHMS1024711</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>LEGAL AND ETHICAL IMPLICATIONS OF CRISPR APPLICATIONS IN PSYCHIATRY<sup><xref ref-type="fn" rid="FN257">*</xref></sup></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Foulkes</surname>
<given-names>Alexandra L.</given-names>
</name>
<xref ref-type="aff" rid="A1">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soda</surname>
<given-names>Takahiro</given-names>
</name>
<xref ref-type="aff" rid="A2">***</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farrell</surname>
<given-names>Martilias</given-names>
</name>
<xref ref-type="aff" rid="A3">****</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giusti-Rodríguez</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="A4">*****</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lázaro-Muñoz</surname>
<given-names>Gabriel</given-names>
</name>
<xref ref-type="aff" rid="A5">******</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>**</label>J.D. University of Houston Law Center, 2019. M.S. Neuroscience, University College London</aff>
<aff id="A2"><label>***</label>Child &amp; Adolescent Psychiatry Fellow, University of North Carolina Hospitals. M.D., Harvard Medical School. Ph.D. Brain and Cognitive Sciences, Massachusetts Institute of Technology</aff>
<aff id="A3"><label>****</label>Research Assistant Professor, University of North Carolina at Chapel Hill, Department of Genetics. Ph.D. Pharmacology, University of North Carolina</aff>
<aff id="A4"><label>*****</label>Research Assistant Professor, University of North Carolina at Chapel Hill, Department of Genetics. Ph.D. Cell and Developmental Biology, Harvard University</aff>
<aff id="A5"><label>******</label>Assistant Professor, Baylor College of Medicine, Center for Medical Ethics and Health Policy. Ph.D. Neuroscience, New York University. J.D. University of Pennsylvania School of Law. MBE (Bioethics), University of Pennsylvania Perelman School of Medicine</aff>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>97</volume>
<issue>5</issue>
<fpage>1359</fpage>
<lpage>1398</lpage>
<abstract id="ABS1">
<p id="P1">Gene-environment interactions play a key role in how psychiatric disorders manifest and develop. Psychiatric genetics researchers are making progress in identifying genomic correlates of many disorders. And recently, the field of genetics has given rise to a technology that many claim will revolutionize the biological sciences and propel the field into a transformative phase: the powerful gene-editing tool known as CRISPR-Cas9. This Article illustrates which psychiatric conditions are likely to make an attractive target for CRISPR as the technology evolves and CRISPR therapies becomes a viable tool to manage or prevent disorders in a clinical setting. We examine the potential scientific and clinical challenges of applying CRISPR in the mental health context, along with the regulatory, ethical, and legal issues that might arise as a consequence of these applications.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>